Menu
Program Committee
-
Sandra A. Milligan, DIAFellow, JD, MD • Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety
Merck Research Laboratories, United States -
J. Lynn Bass, PharmD • Director, Medical Science Liaisons, Americas
Santen, Inc., United States -
Annetta C. Beauregard, MBA, MS • Vice President, US Regulatory Strategy
EMD Serono, Inc., United States -
Larry A. Blankstein, PhD • Head of Clinical Operations
Synlogic, United States -
Linda Bowen, MSc, RAC • Assistant Professor
Temple University, United States -
Joan Buenconsejo, PhD, MPH • Director and Biometrics Team Leader
AstraZeneca, United States -
Jonca C. Bull, MD • Vice President, Regulatory Consulting
PPD, United States -
Thomas M. Casola, MBA • Head, Global Regulatory Affairs, Advertising and Promotion
Shire Specialty Pharmaceuticals, United States -
Nancie E. Celini, DrPH • Chief Health Technology Advisor and Educator
CAB Inc., United States -
Leah Christl, PhD • Associate Director for Therapeutic Biologics, TBBS, OND, CDER
FDA, United States -
Anne B. Cropp, PharmD • Vice President
Pfizer Inc, United States -
Nancy A. Dreyer, DIAFellow, PhD, MPH, FISPE • Global Chief, Sci Affairs; Sr VP, Head, Center for Advanced Evidence Generation
IQVIA, United States -
Charles Drucker, MBA • Director of Operations and Project Management
Quest Diagnostics, United States -
Lauren Edelstein Henry • Senior Principal Operational Specialist
Janssen Pharmaceutical Companies of Johnson & Johnson, United States -
Kathleen Findlen • Head of Clinical Operations and Project Management
Piramal Life Sciences, United States -
Ron D. Fitzmartin, DIAFellow, PhD, MBA • Senior Advisor, Office of Strategic Programs, CDER
FDA, United States -
Michael Folkendt, MS • Associate Director For Regulatory Affairs
FDA, United States -
Stacey M. Fung, PharmD • Associate Director, Medical Communications
Genentech, A Member of the Roche Group, United States -
Jonathan Haddad, MPH • Director, Clinical Statistics
GlaxoSmithKline, United States -
Martin Harvey Allchurch, LLM • Principal International Affairs Officer
European Medicines Agency, European Union, United Kingdom -
Alan M. Hochberg • Scientific Enablement Leader
F. Hoffmann-La Roche Ltd., Switzerland -
Mark J. Hope • Vice President, Global Head of Regulatory Affairs
UCB SA, Switzerland -
Chris Hoyle, MBA • Executive Director
Elite Research Network, United States -
David Jacobson-Kram, PhD • Associate Director for Pharmacology and Toxicology, Office of New Drugs, CDER
FDA, United States -
Nirdosh Jagota, PhD • Vice President and Head, Regulatory CMC
Merck & Co., Inc., United States -
Janet Jenkins-Showalter • Head, US Regulatory Policy
Genentech, A Member of the Roche Group, United States -
Agnes V. Klein, MD • Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products
Health Canada, Canada -
Tatsuo Kurokawa, PhD • President
Japan Self-Medication Industry, Japan -
Sheila Lapping • Senior Director, Outsourcing Management
Takeda Global Research & Development Center Inc., United States -
Jeffrey Litwin, MD, FACC • CEO MedAvante / ProPhase
WIRB-Copernicus Group, United States -
Barry Mangum, PharmD • Chief Executive Officer
Paidion Research, Inc., United States -
JeanMarie Markham • Chief Executive Officer
Clinlogix, United States -
Christopher M. Marrone, PharmD • Real World Outcomes Liaison
Eli Lilly and Company, United States -
Munish Mehra, PhD • Executive Director
Tigermed Co., Ltd., United States -
Jon Meyer, MBA, MSc • Co-Founder and Managing Member
Life Science Strategy Group, LLC, United States -
C. Latham Mitchell, MD • Managing Principal
Erudita Biotechnical LLC, United States -
Christine M. V. Moore, PhD • Global Head and Executive Director, GRACS CMC - Policy
Merck Research Laboratories, United States -
Patrick C. O'Brien, JD, PharmD • General Counsel
Arrowhead Research Corporation, United States -
Shaghig Palanjian, MBA • Vice President, Global Head, R&D QA and Compliance
United States -
James L. Parmentier, PhD • Professor
Retired, United States -
Pradip Paul, MD, MS • Consultant
Strategic Pharmacovigilance and Risk Management, United States -
Kirsten H. Paulson, MS, RAC • Senior Director, Global CMC Medical Devices
Pfizer Inc, United States -
Kim Quaintance-Lunn • Vice President, Regulatory Policy, NA
Bayer, United States -
Badri Rengarajan, MD • Medical Affairs Lead, ASPIRE Unit
Actelion, United States -
Margaret Richards, PhD, MPH • Executive Director, Scientific Affairs, Real-World Solutions
PRA Health Sciences, United States -
Lucy Rose, MBA • President
Lucy Rose and Associates, LLC, United States -
Abdul J. Sankoh, PhD, MA, MS • Vice President, Data Science
Sage Therapeutics, Inc. , United States -
Gregg Schneider • Director, R&D Financial Management
Otsuka Pharmaceutical Development & Commercialization, Inc., United States -
Suzanne Sensabaugh, MBA, MS • President and Principal Consultant
HartmannWillner LLC, United States -
Leigh Shultz, PhD • Associate Vice President, Project Management
Merck & Co., Inc., United States -
Ling Su, DIAFellow, PhD • Past President, DIA Board of Directors; Professor
Shenyang Pharmaceutical University, China -
Patrick J. Thomas, MS • Director, US Group Lead - Adult & Travellers Vaccines
GlaxoSmithKline, United States -
Carolynn Thomas-Jones •
The Ohio State University, United States -
Toshiyoshi Tominaga, PhD • Associate Executive Director (for International Programs)
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Jurgen Venitz, MD, PhD • Professor, Dept of Pharmaceutics, Pharmacotherapy & Outcomes Sci, Dir PK/PD Lab
Virginia Commonwealth University, United States -
Keith W. Wenzel • Senior Director, Solution Incubator
PAREXEL, United States -
Albert I. Wertheimer, PharmD, PhD, MBA • Professor of Pharmacy Administration, School of Pharmacy
Temple University, United States -
Linda Fossati Wood, MPH, RN • President
MedWrite, Inc., United States